<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04001335</url>
  </required_header>
  <id_info>
    <org_study_id>1298/19</org_study_id>
    <nct_id>NCT04001335</nct_id>
  </id_info>
  <brief_title>Diagnosis of Cutaneous Leishmaniasis Using the CL-detect Rapid Test in Travelers and Migrants in Belgium</brief_title>
  <acronym>RapidLeish</acronym>
  <official_title>Diagnosis of Cutaneous Leishmaniasis Using the CL-detect Rapid Test in Travelers and Migrants in Belgium</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institute of Tropical Medicine, Belgium</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institute of Tropical Medicine, Belgium</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cutaneous Leishmaniasis (CL) is a neglected tropical disease which is increasingly seen in
      travelers and migrants evaluated in travel clinics of non-endemic countries. Various CL
      species are present in different parts of the world, and these different species vary in
      severity, prognosis and therapeutic approaches.

      At ITM, diagnosis of CL in suspected patients is done using a skin biopsy, analyzed by
      diagnostic PCR, and species typing PCR. This method is invasive, and diagnosis is often
      delayed for days to weeks.

      The new antigen-based CL Detect Rapid Test uses dental broach sampling and has results within
      30 minutes. Dental broach samples left over from the Cl Detect Rapid test may still be used
      for PCR including species typing.

      How well the CL Detect Rapid Test performs in the varied population of a travel clinic and
      whether it is possible to use dental broach sampling for further PCR tests in this population
      needs to be evaluated The aim of this study is to study the performance of the CL Detect
      Rapid Test and whether dental broach sampling can replace skin biopsy for CL at ITM.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 12, 2019</start_date>
  <completion_date type="Anticipated">September 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Diagnostic accuracy of CL detect RDT</measure>
    <time_frame>2019-2010</time_frame>
    <description>Against combined reference of microscopy and PCR using skin punch biopsy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Proportion of PCR positives on dental broach sample</measure>
    <time_frame>2019-2020</time_frame>
    <description>Compared to PCR positives on skin punch biopsy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of successful species typing on dental broach sample</measure>
    <time_frame>2019-2020</time_frame>
    <description>Compared to successful species typing on skin punch biopsy sample</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">62</enrollment>
  <condition>Cutaneous Leishmaniases</condition>
  <arm_group>
    <arm_group_label>CL suspicion</arm_group_label>
    <description>Patients with skin lesions suspected to be cutaneous leishmaniasis</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Dental Broach</intervention_name>
    <description>Dental broach, RDT and PCR</description>
    <arm_group_label>CL suspicion</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with suspicion of CL will be screened for inclusion.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Skin biopsy for leishmania test requested by treating ITM clinician OR

          -  externally requested skin biopsy for Leishmania tested at ITM with an ITM consultation
             &lt;7 days of the biopsy sample

          -  willing and able to provide consent/assent

          -  not on CL treatment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Saskia van Henten, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute of Tropical Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Johan van Griensven, MD,PhD</last_name>
    <role>Study Director</role>
    <affiliation>Institute of Tropical Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Saskia van Henten, MD</last_name>
    <phone>032470556</phone>
    <phone_ext>32</phone_ext>
    <email>svanhenten@itg.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lieselotte Cnops, PhD</last_name>
    <phone>032470807</phone>
    <phone_ext>32</phone_ext>
    <email>lcnops@itg.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Institute of Tropical Medicine</name>
      <address>
        <city>Antwerp</city>
        <zip>2000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Saskia van Henten, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>June 26, 2019</study_first_submitted>
  <study_first_submitted_qc>June 26, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 28, 2019</study_first_posted>
  <last_update_submitted>August 14, 2019</last_update_submitted>
  <last_update_submitted_qc>August 14, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 15, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Leishmaniasis</mesh_term>
    <mesh_term>Leishmaniasis, Cutaneous</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

